Castle Biosciences CSTL
NASDAQ CSTL
$33.79 -0.71 (-2.06%)
At close: Nov 13, 2026 · 4:00 PM EST

Castle Biosciences (CSTL) Current Deferred Revenue (2020 - 2021)

Updated

Castle Biosciences (CSTL) reported Current Deferred Revenue of $3 million for Q3 2021, down 64.1% from $8.35 million a year earlier and down 51.4% from the prior quarter.

Analysis

Castle Biosciences (CSTL) Current Deferred Revenue (2020 - 2021) Analysis & Trends

At the end of FY2020, Castle Biosciences posted Current Deferred Revenue of $6.62 million.

  • Per Business Quant data, the three quarters before Q3 2021 came in at $6.18 million (Q2 2021), $8.18 million (Q1 2021) and $6.62 million (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 105.29 Bn 103.13 Bn 17.03 Bn
2 Natera 46.06 Bn 41.68 Bn 513.47 Mn
3 Labcorp Holdings 30.09 Bn 28.19 Bn 1.11 Bn
4 Quest Diagnostics 28.58 Bn 26.66 Bn 1.04 Bn
5 Guardant Health 20.44 Bn 16.05 Bn 236.15 Mn
6 BrightSpring Health Services 14.16 Bn 11.04 Bn 518.55 Mn
7 Encompass Health 13.83 Bn 14.29 Bn 1.54 Bn
8 Tempus AI 12.69 Bn 9.84 Bn 266.70 Mn
9 Davita 11.06 Bn 9.92 Bn 1.13 Bn
10 Castle Biosciences 1.04 Bn -65.97 Mn 78.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 3.00 Mn
Jun 30, 2021 6.18 Mn
Mar 31, 2021 8.18 Mn
Dec 31, 2020 6.62 Mn
Sep 30, 2020 8.35 Mn
Jun 30, 2020 8.35 Mn
API Access

Castle Biosciences Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CSTL&period=max&api_key=YOUR_API_KEY